Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
SNORA59A: SNORA59A is a small nucleolar RNA (snoRNA) that has been detected in both control and osteoarthritic samples [PMC10094766]. It has been implicated in prostate cancer [PMC8649667] and renal clear cell carcinoma [PMC10050728]. SNORA59A is one of the snoRNAs that play a role in the development of clear cell renal cell carcinoma (ccRCC) and may serve as a diagnostic biomarker for ccRCC patients [PMC7812721]. It has also been identified as a risk factor for tumor metastasis and progression in hepatocellular carcinoma (HCC) [PMC9524901]. SNORA59A is one of the snoRNAs that are significantly related to the prognosis of HCC, and its expression is correlated with neutrophil infiltration [PMC9524901]. The expression of SNORA59A has also been found to be related to Th2 cells and Th17 cells infiltration levels [PMC9524901]. Hypermethylation of CpG islands near the 5'-termini of host genes for SNORA59A has been observed in cancer cells, suggesting its potential role as a specific marker for cancer cells compared to normal human cells [PMC4427830]. The host gene-associated 5'CpG islands of SNORA59A have also been found to be hypermethylated in colorectal cancer cells [PMC7011154]. In summary, SNORA59A is an important snoRNA with potential diagnostic, prognostic, and therapeutic implications in various types of cancer.
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset